DNA Therapeutics SA
http://www.dna-therapeutics.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From DNA Therapeutics SA
Onxeo Seeks Partner For Its Expanding Oncology Pipeline
Onxeo, a biotech company developing drugs for orphan oncology indications, plans to secure financial backing from a pharma partner for its lead product Livatag based on impending Phase III results, CEO Judith Greciet told Scrip in an interview.
Deals In Depth: February 2016
Baxalta signed its first major CART deal, with Precision BioSciences; Stryker spent over $4bn to acquire Sage and Physio-Control. Coherus BioSciences and Kinetic Concepts/KCI USA completed big debt offerings.
Company Information
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice